Search Results - "Sweeney, William E"

Refine Results
  1. 1

    Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease by Zhou, Xia, Fan, Lucy X, Sweeney, Jr, William E, Denu, John M, Avner, Ellis D, Li, Xiaogang

    Published in The Journal of clinical investigation (01-07-2013)
    “…Autosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2 and is characterized by the development of multiple…”
    Get full text
    Journal Article
  2. 2

    HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells by Liu, Wei, Fan, Lucy X, Zhou, Xia, Sweeney, Jr, William E, Avner, Ellis D, Li, Xiaogang

    Published in PloS one (13-11-2012)
    “…We present for the first time that histone deacetylase 6 (HDAC6) regulates EGFR degradation and trafficking along microtubules in Pkd1 mutant renal epithelial…”
    Get full text
    Journal Article
  3. 3

    Src Inhibition Ameliorates Polycystic Kidney Disease by SWEENEY, William E, VON VIGIER, Rodo O, FROST, Philip, AVNER, Ellis D

    “…Despite identification of the genes responsible for autosomal dominant polycystic kidney disease (PKD) and autosomal recessive PKD (ARPKD), the precise…”
    Get full text
    Journal Article
  4. 4

    Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD) by Sweeney, Jr, William E, Avner, Ellis D

    Published in Cell and tissue research (01-12-2006)
    “…Autosomal recessive polycystic kidney disease (ARPKD) belongs to a group of congenital hepatorenal fibrocystic syndromes characterized by dual renal and…”
    Get full text
    Journal Article
  5. 5

    Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy by Sweeney, William E., Avner, Ellis D.

    Published in Pediatric research (01-01-2014)
    “…Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are significant causes of morbidity and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Smac-Mimetic―Induced Epithelial Cell Death Reduces the Growth of Renal Cysts by FAN, Lucy X, XIA ZHOU, SWEENEY, William E, WALLACE, Darren P, AVNER, Ellis D, GRANTHAM, Jared J, XIAOGANG

    “…Past efforts to pharmacologically disrupt the development and growth of renal cystic lesions focused primarily on normalizing the activity of a specific…”
    Get full text
    Journal Article
  8. 8

    Loss of activator of G‐protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents by Regner, Kevin R., Nozu, Kandai, Lanier, Stephen M., Blumer, Joe B., Avner, Ellis D., Sweeney, William E., Park, Frank

    Published in The FASEB journal (01-06-2011)
    “…The intracellular mechanisms underlying renal tubular epithelial cell proliferation and tubular repair following ischemia‐reperfusion injury (IRI) remain…”
    Get full text
    Journal Article
  9. 9

    Diagnosis and management of childhood polycystic kidney disease by Sweeney, William E., Avner, Ellis D.

    Published in Pediatric nephrology (Berlin, West) (01-05-2011)
    “…A number of syndromic disorders have renal cysts as a component of their phenotypes. These disorders can generally be distinguished from autosomal dominant…”
    Get full text
    Journal Article
  10. 10

    Activator of G Protein Signaling 3 Promotes Epithelial Cell Proliferation in PKD by NADELLA, Rama, BLUMER, Joe B, LANIER, Stephen M, PARK, Frank, GUANGFU JIA, KWON, Michelle, AKBULUT, Talha, FENG QIAN, SEDLIC, Filip, WAKATSUKI, Tetsuro, SWEENEY, William E, WILSON, Patricia D

    “…The activation of heterotrimeric G protein signaling is a key feature in the pathophysiology of polycystic kidney diseases (PKD). In this study, we report…”
    Get full text
    Journal Article
  11. 11

    Role of genetic modifiers in an orthologous rat model of ARPKD by O'Meara, Caitlin C, Hoffman, Matthew, Sweeney, Jr, William E, Tsaih, Shirng-Wern, Xiao, Bing, Jacob, Howard J, Avner, Ellis D, Moreno, Carol

    Published in Physiological genomics (01-08-2012)
    “…Human data and animal models of autosomal recessive polycystic kidney disease (ARPKD) suggest that genetic factors modulate the onset and severity of the…”
    Get full text
    Journal Article
  12. 12

    20-HETE Mediates Proliferation of Renal Epithelial Cells in Polycystic Kidney Disease by PARK, Frank, SWEENEY, William E, GUANGFU JIA, ROMAN, Richard J, AVNER, Ellis D

    “…Polycystic kidney diseases are characterized by abnormal proliferation of renal epithelial cells. In this study, the role of 20-hydroxyeicosatetraenoic acid…”
    Get full text
    Journal Article
  13. 13

    Emerging Therapies for Childhood Polycystic Kidney Disease by Sweeney, Jr, William E, Avner, Ellis D

    Published in Frontiers in pediatrics (19-04-2017)
    “…Cystic kidney diseases comprise a varied collection of hereditary disorders, where renal cysts comprise a major element of their pleiotropic phenotype. In…”
    Get full text
    Journal Article
  14. 14

    EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats by Torres, Vicente E., Sweeney, William E., Wang, Xiaofang, Qian, Qi, Harris, Peter C., Frost, Philip, Avner, Ellis D.

    Published in Kidney international (01-11-2003)
    “…EGF receptor tyrosine kinase inhibition attenuates the development of PKD in the Han:SPRD rats. Increasing evidence supports an important role for the…”
    Get full text
    Journal Article
  15. 15

    Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD by Park, Frank, Sweeney, Jr, William E, Jia, Guangfu, Akbulut, Talha, Mueller, Benjamin, Falck, J Russell, Birudaraju, Saritha, Roman, Richard J, Avner, Ellis D

    “…20-Hydroxyeicosatetraenoic acid (20-HETE) has been implicated as a potential mediator in epithelial cell proliferation and cyst formation in polycystic kidney…”
    Get more information
    Journal Article
  16. 16

    EGF-related growth factors in the pathogenesis of murine ARPKD by DELL, Katherine Macrae, NEMO, Raghad, SWEENEY, William E, AVNER, Ellis D

    Published in Kidney international (01-06-2004)
    “…Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha) and their receptor, EGFR, play key roles in polycystic kidney disease (PKD)…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats by Torres, Vicente E., Sweeney, William E., Wang, Xiaofang, Qian, Qi, Harris, Peter C., Frost, Philip, Avner, Ellis D.

    Published in Kidney international (01-11-2004)
    “…Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Advances in the understanding of cystogenesis, identification of the…”
    Get full text
    Journal Article
  19. 19

    Renal Cystic Disease: New Insights for the Clinician by Avner, Ellis D., Sweeney, William E.

    Published in The Pediatric clinics of North America (01-10-2006)
    “…This article cannot comprehensively cover the enormous strides made in defining the molecular and cellular basis of renal cystic diseases over the last decade…”
    Get full text
    Journal Article
  20. 20

    Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability by Sweeney, William E., Hamahira, Kiyoshi, Sweeney, Jennifer, Garcia-Gatrell, Michelle, Frost, Philip, Avner, Ellis D.

    Published in Kidney international (01-10-2003)
    “…Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. We have previously demonstrated an essential role…”
    Get full text
    Journal Article